Archive for April 25th, 2009|Daily archive page

Strength and determination help paralyzed woman walk on 21st birthday????

In ALL ARTICLES, VICTORIES & SUCCESS STORIES on April 25, 2009 at 11:41 pm

What a great article about Kadi DeHaan! As you know, I have been pointing out the disparity of media coverage regarding real, safe and successful adult versus pie in the sky and misleading possibilities of embryonic stem cell therapies expected in 10-20 years. You have put your finger on an instant classic. The article title for this story is:

Strength and determination help paralyzed woman walk on 21st birthday

So I certainly applaud her strength and determination and there is no doubt that without them this amazing accomplishment wouldn’t have been possible. I want to take nothing away from her…

And yet, out of respect to the thousands of other SCI patients who have shown equal strength and determination, often for much longer than Ms DeHaan has, I feel it is my duty to add that it was probably not as much her qualities of strength and determination but rather the ADULT STEM CELL THERAPY that she received 7 times in 3 years that truly allowed her recovery. -dg

April 25, 2009

“They Don’t Know What Else is Out There”

Filed under: adult stem cell awareness, alternative sources — chelseaz @ 4:33 pm

Video of Kadi DeHaan from Michigan who was paralyzed in a car accident four years ago and has benefited from treatments using stem cells derived from her own bone marrow

She really nails it here when she says that when you mention stem cells many people assume you’re talking about embryonic and “don’t know what else is out there.” Either they are totally unaware of any alternatives or they think that ESCs are the only ones capable of treating patients. For example, a survey last year found that more people think that embryonic, rather than adult, stem cells have already resulted in cures and treatments.

The reality, of course, is that ACSs have had tremendous success in human patients with various diseases and disabilities whereas ESCs have successfully treated nothing significantly – in mice, let alone humans! And yet the ESCR hype remains. Some now even go so far as to guarantee the disease fighting power of therapeutic cloning

It should be quite obvious by now that results don’t really matter so long as it looks like something is being done to maybe, someday, possibly eradicate disease and suffering. Unfortunately in this case that something involves the intentional use and destruction of tiny human beings.


Molecular ‘Key’ To Successful Blood Stem Cell Transplants Discovered

In ALL ARTICLES, SCIENCE & STEM CELLS on April 25, 2009 at 11:10 pm


ScienceDaily (Apr. 25, 2009) — University of British Columbia researchers have discovered a “molecular key” that could help increase the success of blood stem cell transplants, a procedure currently used to treat diseases such as leukemia, Hodgkin’s lymphoma and aplastic anemia.

During a blood stem cell transplant, donor blood stem cells – which can produce red and white blood cells and platelets – are injected into the recipient to produce new blood. The stem cells then need to travel to the thymus – an organ near the heart – and produce T-cells, a type of white blood cell that orchestrates the body’s immune system.

A common problem with blood stem cell transplants is the failure of stem cells to repopulate the thymus and generate T-cells. Without T-cells the patient is unable to fight infection and post-transplant prognosis is poor.

Now Prof. Hermann Ziltener and his research team at UBC’s Biomedical Research Centre have identified a molecule called S1P that can tell the thymus to “open the gates” and accept more stem cells.

“This discovery gives us a handle on determining whether the thymus will be receptive to migrating stem cells,” says Ziltener, a professor in the Dept. of Pathology and Laboratory Medicine. “By treating patients with drugs that control S1P, scientists can now manipulate the thymic gates to either open or close.”

The same team had previously identified a number of molecules that function as the thymic gates for migrating stem cells. The new study, published in the April issue of The Journal of Experimental Medicine, is the first to hone in on the “key” molecule that can open the thymic gate.

Next steps in the research include finding the mechanism T-cells in blood use to control S1P formation. Researchers estimate that it would be at least five years before the discovery can be translated into a clinical test

via Molecular ‘Key’ To Successful Blood Stem Cell Transplants Discovered.

See also:

Health & Medicine

* Stem Cells

* Prostate Cancer

* Lymphoma

* Brain Tumor

* Immune System

* Anemia


* T cell

* Embryonic stem cell

* Somatic cell

* Bone marrow transplant


In ALL ARTICLES on April 25, 2009 at 9:19 pm

I spent the last 2 days in NY meeting with a number of big shots in the stem cell industry and a few others.  There was an incredible exchange of ideas and it was very exhilarating.  There are great things on the horizon!


%d bloggers like this: